Transmission of LDLR mutation from donor through liver transplantation resulting in hypercholesterolemia in the recipient

American Journal of Transplantation

Volumn 14, Issue 12, 2014, Pages 2898-2902

  Nikkila K ^a   Aberg F ^a   Isoniemi, H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Clinical research practice; disease pathogenesis; donors and donation; genetics; hyperlipidemia; liver disease: congenital; liver transplantation hepatology; translational research science

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CYCLOSPORIN; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; METHYLPREDNISOLONE; RAPAMYCIN; ROSUVASTATIN; SIMVASTATIN; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER SURGERY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DIARRHEA; DISEASE TRANSMISSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GRAFT RECIPIENT; HEMANGIOENDOTHELIOMA; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVER TUMOR; OBESITY; POSTOPERATIVE PERIOD; ADVERSE EFFECTS; DONOR; GENETICS; HEMANGIOENDOTHELIOMA, EPITHELIOID; LIVER NEOPLASMS; MUTATION; PROGNOSIS;

ADULT; FEMALE; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; HYPERCHOLESTEROLEMIA; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MUTATION; PROGNOSIS; RECEPTORS, LDL; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 84910634844     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12961     Document Type: Article

References (24)

1. Ison MG, Nalesnik MA., An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 1123-1130.
2. Pungpapong S, Krishna M, Abraham SC, Keaveny AP, Dickson RC, Nakhleh RE., Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl 2006; 12: 310-315.
3. Teperman L., Donor-transmitted diseases. Liver Transpl 2010; 16: S40-S44.
4. Okamoto S, Wixner J, Obayashi K, et al. Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transpl 2009; 15: 1229-1235.
5. Schmidt HH-J, Tietge UJF, Buettner J, et al. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p. W577R LDL-receptor gene mutation. Clin Transplant 2008; 22: 180-184.
6. Ibrahim M, El-Hamamsy I, Barbir M, Yacoub MH., Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively. J Cardiovasc Transl Res 2012; 5: 351-358.
7. Alkofer BJ, Chiche L, Khayat A, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolaemia: Report of the first case and review of the literature. Transplant Proc 2005; 37: 2250-2252.
8. Hobbs HH, Brown MS, Goldstein JL., Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-466.
9. Van Craeyveld E, Jacobs F, Gordts SC, De Geest B., Review article: Gene therapy for familial hypercholesterolemia. Curr Pharm Des 2011; 17: 2575-2591.
10. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG., Familial hypercholesterolemia in the Danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012; 97: 3956-3964.
11. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478-3490a.
12. Watt KDS., Obesity and metabolic complications of liver transplantation. Liver Transpl 2010; 16: S65-S71.
13. Huijgen R, Kindt I, Defesche JC, Kastelein JJP., Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: A study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants. Eur Heart J 2012; 33: 2325-2330.
14. Åberg F, Isoniemi H, Höckerstedt K., Long-term results of liver transplantation. Scand J Surg 2011; 100: 14-21.
15. Åberg F, Jula A, Höckerstedt K, Isoniemi H., Cardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general population. Transplantation 2010; 89: 61-68.
16. Sethi A, Stravitz RT., Review article: Medical management of the liver transplant recipient-A primer for non-transplant doctors. Aliment Pharmacol Ther 2007; 25: 229-245.
17. Vartiainen E, Borodulin K, Sundvall J, et al. FINNRISKI-tutkimus: Väestön kolesterolitaso on vuosikymmenien laskun jälkeen kääntynyt nousuun (English summary: Cholesterol levels in the Finnish population have increased after decades of decline). Suomen Lääkärilehti 2012; 67: 2364-2368.
18. Gabe SM, Bjarnason I, Tolou-Ghamari Z, et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 1998; 115: 67-74.
19. Robinson JG., Management of familial hypercholesterolemia: A review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Manag Care Pharm 2013; 19: 139-149.
20. Rader DJ, Cohen J, Hobbs HH., Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest 2003; 111: 1795-1803.
21. Usifo E, Leigh SE, Whittall RA, et al. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: Update and pathological assessment. Ann Hum Genet 2012; 76: 387-401.
22. Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM., Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver Transpl 2009; 15: 504-508.
23. Ginanni Corradini S, Siciliano M, Parlati L, et al. Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. Liver Int 2014; 34: e290-e301.
24. Etxebarria A, Palacios L, Stef M, et al. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor. Hum Mutat 2012; 33: 232-243.